Sort
17,054 grants matching “genome editing”
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions, Grant Number 5UM1HG009426-03
$244,566Kevin P White · Tempus Labs, Inc. · UM1 · FY2019 · HG
Generation of a new model for Usher syndrome.
$244,500Huaiyu Hu · Upstate Medical University · R21 · FY2024 · EY
Development of in Vivo Base Editing as a Genetic Treatment for Spinal Muscular Atrophy
$244,458Christiano Alves · Massachusetts General Hospital · K01 · FY2024 · NS
Genome engineering tools for functional screening of non-coding elements
$244,439Neville Sanjana · New York Genome Center · R00 · FY2017 · HG
Regulation of Cytoplasmic Dynein Motility in Neuronal Transport
$244,377Richard James McKenney · University Of California At Davis · R00 · FY2017 · NS
Sequential ion/ion reactions for large peptide and whole protein characterization
$244,290Joshua J Coon · University Of Wisconsin-Madison · R01 · FY2008 · GM
Bioinformatics Shared Resource
$244,270Andrew V Kossenkov · Wistar Institute · P30 · FY2020 · CA
CRISPR-based editing of RNA and cellular mechanisms that govern RNA repair
$244,268Artem Aleksandrovich Nemudryi · University Of Florida · R00 · FY2025 · AI
Genomic and functional analysis of active DNA demethylation in mammalian cells
$244,217Hao Wu · University Of Pennsylvania · R00 · FY2017 · HG
Methods for mammalian genetic analysis
$244,193Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Gene Editing of the Beta Globin Gene Using TAL Effector Nucleases and single stranded oligonucleotides
$244,042Dula Man · Nemours Children'S Hospital, Delaware · P20 · FY2015 · GM
Gene Editing of the Beta Globin Gene Using TAL Effector Nucleases and single stranded oligonucleotides
$244,042Dula Man · Nemours Children'S Hospital, Delaware · P20 · FY2016 · GM
Development of in Vivo Base Editing as a Genetic Treatment for Spinal Muscular Atrophy
$244,025Christiano Alves · Massachusetts General Hospital · K01 · FY2025 · NS
Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells
$244,019Floris Barthel · Translational Genomics Research Inst · R00 · FY2023 · CA
Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells
$244,019Floris Barthel · Translational Genomics Research Inst · R00 · FY2022 · CA
An effective statistical inference framework to develop innovative compensations for protein mutations
$243,840Zhao Ren · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · GM
Elucidating the immune response of Schreiber's bats to Lloviu virus infection in vitro and in vivo
$243,800Elke C Muhlberger · Boston University Medical Campus · R21 · FY2022 · AI
A novel ChIP-spec technology to isolate protein complexes at unique genomic loci
$243,750Richard A Young · Whitehead Institute For Biomedical Res · R21 · FY2013 · HG
A novel ChIP-spec technology to isolate protein complexes at unique genomic loci
$243,750Richard A Young · Whitehead Institute For Biomedical Res · R21 · FY2014 · HG
A Cell-specific modified CRISPR/Cas9 system for conditional gene disruption in Aedes aegypti
$243,750Paul A Garrity · Brandeis University · R21 · FY2023 · AI
Development of FRESH (Fast Rescue Employing Self-Helper virus) - a rapid, generalizable method to rescue infectious virus from noninfectious genomic material
$243,750Lauren Marie Oldfield · J. Craig Venter Institute, Inc. · R21 · FY2020 · AI
Genome Engineering Core
$243,747Frederic D Bushman · University Of Pennsylvania · P01 · FY2025 · AI
Investigating the role of KLF5 genomic alterations in tumorigenesis
$243,715Xiaoyang Zhang · University Of Utah · R00 · FY2020 · CA
Antimicrobial peptides as models for the evolution of gene duplication
$243,669Robert L Unckless · University Of Kansas Lawrence · R00 · FY2018 · GM
Cryptosporidium mutagenesis
$243,665Giovanni Widmer · Tufts University Boston · R21 · FY2024 · AI